Clinical trial
Efficacy of Histidine-Tryptophan-Ketoglutarate Solution Versus Blood Cardioplegia in Coronary Artery Bypass Graft Surgery: A Randomized Double Blinded Study
NCT04203680 is registered in ClinicalTrials.gov with Ain Shams University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Histidine-Tryptophan-Ketoglutarate Solution Versus Blood Cardioplegia in Coronary Artery Bypass Graft Surgery: A Randomized Double Blinded Study
- Lead sponsor
- Ain Shams University
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- December 25, 2019
- Completion date
- April 25, 2020
- Enrollment
- 320 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
cardioplegia solution adverse reaction